SCOTTSBLUFF, Neb., – Regional West Medical Center today issued assurances that it uses no medication from the Massachusetts compounding center associated with the nation’s fungal meningitis outbreak.

Patients who received methylprednisolone acetate injections at Regional West have no cause for concern.

“We do not purchase any of our drugs from New England Compounding Center, which is the pharmacy that is involved with this problem,” said Ron Bahnsen, pharmacy director.

Regional West Health Services is the parent company for Regional West Medical Center and Regional West Physicians Clinic. These organizations, with over 1,800 employees, provide comprehensive and innovative health care services for the people and communities of western Nebraska and the neighboring states of Colorado, South Dakota and Wyoming. With over 110 active physicians, 95 percent of whom are board certified or board eligible, plus an additional 25 consulting specialists, the Regional West family of health care organizations offers care that spans more than 30 medical specialties.